Imunon Q2 EPS $(0.51) Beats $(0.60) Estimate
Portfolio Pulse from Benzinga Newsdesk
Imunon (NASDAQ:IMNN) reported a Q2 EPS of $(0.51), beating the analyst consensus estimate of $(0.60) by 15%. This represents a 16.39% improvement over the $(0.61) loss per share from the same period last year.
August 14, 2024 | 12:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Imunon reported a Q2 EPS of $(0.51), beating the analyst consensus estimate of $(0.60) by 15%. This is a 16.39% improvement over the $(0.61) loss per share from the same period last year.
Beating earnings estimates by 15% and showing a significant year-over-year improvement in EPS is likely to positively impact Imunon's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100